glp-1 obesity drug news today october 23 2025 Receptor Agonists Drugs Market Size, Trends, Growth Report 2032 Market Overview: GLP-1 Agonists and

Pharmacogenetics of glucagon-like peptide-1 agonists for the treatment of type 2 diabetes mellitus

Sleep and stress regulation Inadequate rest and chronic stress elevate cortisol, which can counteract fat loss and trigger cravings

GLP-1 RA improves diabetic retinopathy by protecting the blood-retinal barrier through GLP-1R-ROCK-p-MLC signaling pathway

Effects of exenatide on measures of diabetic neuropathy in subjects with type 2 diabetes: results from an 18-month proof-of-concept open-label randomized study

Response rates vary by molecule newer agents such as tirzepatide and semaglutide yield higher responder rates (~86%91%) than older agents such as exenatide or liraglutide (~40%65%) (223) and vary by baseline BMI, sex, and glycemic status, with women and individuals with higher BMI responding better (222, 224)

doi:10.1016/j.bbr.2019.112359 84